Oncternal Therapeutics Inc. buy Oppenheimer Holdings Inc.
Start price
22.03.23
/
50%
€0.60
Target price
22.03.24
€8.34
Performance (%)
-55.62%
End price
23.03.24
-
Summary
This prediction is currently being closed. Massive losses of -55.62% have been the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $14.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for ONCT provided by MarketBeat
In the thread Trading Oncternal Therapeutics Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten